Search results

Skip to results

Type

Type

Last updated

Last updated

Advice programme

Showing 1 result for ingenol mebutate

  1. Actinic keratosis: ingenol mebutate gel (ESNM14)

    This evidence summary has been withdrawn as the licence of ingenol mebutate gel has been suspended.

    Evidence summary
    Published
    19 March 2013